This study was run to characterize the real-world CAR-T patient population by describing demographic...
Blog
Use this space to tell everyone about what you have to offer.
This study was run to characterize patient demographics, cancer indications, treatment patterns, and...
As the healthcare industry continues to face data challenges, PurpleLab® is making significant inves...
Although randomized controlled trials remain a cornerstone of evidence generation, pharmaceutical an...
Biomarker testing guides selection of targeted therapies in non–small cell lung cancer (NSCLC). Desp...
This article was written by PharmaPhorum. Clinical trials are designed to evaluate the safety and ef...
Download the Webinar Today In pharmaceutical development, where most therapies never reach the marke...
We’re excited to share an important milestone at PurpleLab: we’ve officially submitted our first-eve...
Healthcare is evolving. We used to focus purely on addressing specific symptoms and treating specifi...
Generic drugs don’t usually grab headlines. They’re dependable, low-cost and mostly stay in the back...